DiaMedica management to participate in four September investor conferences
DiaMedica Therapeutics management will participate in four upcoming investment bank conferences in September, the company said.
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction and acute ischemic stroke, today announced that company management will participate in four upcoming investment bank conferences i…